Insulin
Active pharmaceutical substance formulated in Jan Aushadhi generic products for Diabetes & Endocrine treatment.
🧴 Clinical Application
Inject subcutaneously as directed by your diabetologist before meals. Rotate injection sites daily.
⚠️ Side Effects
Common: Hypoglycemia, lipodystrophy, injection site pain. Rare/Severe: Hypoglycemic coma, severe hypokalemia.
🛡️ Safety Warnings
Ensure correct unit measurement. Always have glucose handy. Never share insulin pens or needles.
Jan Aushadhi Products containing Insulin
Found 5 generic formulation(s) containing this active ingredient.
Soluble Insulin Injection 40 IU per ml (R-DNA Origin)
Recombinant Human Insulin therapy on the WHO Model List of Essential Medicines. Restores glycemic control, facilitates glucose uptake, and suppresses hepatic glucose production in diabetes mellitus.
Biphasic Isophane Insulin Injection 40 IU/ml (30/70)
Recombinant Human Insulin formulation (Regular human insulin, Isophane NPH intermediate-acting insulin, or Biphasic premixed human/analogue insulin) on the WHO Model List of Essential Medicines. It replaces deficient endogenous insulin, binding to membrane insulin receptor tyrosine kinase to promote cellular glucose uptake into skeletal muscle and adipose tissue, stimulate glycogen and protein synthesis, and inhibit lipolysis and hepatic gluconeogenesis. Indicated for type 1 diabetes mellitus, type 2 diabetes mellitus uncontrolled on oral therapies, gestational diabetes, and diabetic ketoacidosis.
Biphasic Isophane Insulin Injection (50:50) 40 IU per ml
Recombinant Human Insulin formulation (Regular human insulin, Isophane NPH intermediate-acting insulin, or Biphasic premixed human/analogue insulin) on the WHO Model List of Essential Medicines. It replaces deficient endogenous insulin, binding to membrane insulin receptor tyrosine kinase to promote cellular glucose uptake into skeletal muscle and adipose tissue, stimulate glycogen and protein synthesis, and inhibit lipolysis and hepatic gluconeogenesis. Indicated for type 1 diabetes mellitus, type 2 diabetes mellitus uncontrolled on oral therapies, gestational diabetes, and diabetic ketoacidosis.
Biphasic Isophane Insulin Injection 100 IU/ml (30/70)
Recombinant Human Insulin formulation (Regular human insulin, Isophane NPH intermediate-acting insulin, or Biphasic premixed human/analogue insulin) on the WHO Model List of Essential Medicines. It replaces deficient endogenous insulin, binding to membrane insulin receptor tyrosine kinase to promote cellular glucose uptake into skeletal muscle and adipose tissue, stimulate glycogen and protein synthesis, and inhibit lipolysis and hepatic gluconeogenesis. Indicated for type 1 diabetes mellitus, type 2 diabetes mellitus uncontrolled on oral therapies, gestational diabetes, and diabetic ketoacidosis.
Soluble Insulin Injection 100 IU per ml (R-DNA Origin)
Recombinant Human Insulin therapy on the WHO Model List of Essential Medicines. Restores glycemic control, facilitates glucose uptake, and suppresses hepatic glucose production in diabetes mellitus.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Insulin.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Soluble Insulin Injection 40 IU per ml (R-DNA Origin) | 10 ml Vial | ₹85.91 | N/A | N/A | N/A |
| Biphasic Isophane Insulin Injection 40 IU/ml (30/70) | 10 ml Vial | ₹91.35 | N/A | N/A | N/A |
| Biphasic Isophane Insulin Injection (50:50) 40 IU per ml | 10 ML VIAL | ₹96.80 | N/A | N/A | N/A |
| Biphasic Isophane Insulin Injection 100 IU/ml (30/70) | 3 ml Catridge | ₹181.50 | N/A | N/A | N/A |
| Soluble Insulin Injection 100 IU per ml (R-DNA Origin) | 3 ml Catridge | ₹170.00 | N/A | N/A | N/A |
Frequently Asked Questions (FAQ)
Get answers to common queries about Insulin generics.